Neupogen and Armodafinil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Armodafinil (armodafinil). Common drug interactions include pain among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Armodafinil. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Armodafinil?

Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.

On Jul, 31, 2026

20 people who take Neupogen and Armodafinil together, and have interactions are studied.

Neupogen and Armodafinil drug interactions.

What are the common drug interactions of Neupogen and Armodafinil, by gender? *:

female:

Pain
Rash
Rib fracture
Aortic arteriosclerosis (hardening of the aortic arteries)
Asthenia (weakness)
Bone disorder
Chest pain
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Cutis laxa (connective tissue disorder in which the skin lacks elasticity and hangs in loose folds)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Facial pain
Hypertension (high blood pressure)
Neuropathy peripheral (surface nerve damage)
Pain in jaw
Sinusitis (inflammation of sinus)
Weight decreased
Hypotension (abnormally low blood pressure)
Abdominal discomfort

What are the common drug interactions of Neupogen and Armodafinil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pain
Arthralgia (joint pain)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Deformity (disfigurement)
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Eyelid ptosis (falling of the upper or lower eyelid)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Hepatic cyst
Intervertebral disc protrusion (spinal disc protrusion)

60+:

Hypotension (abnormally low blood pressure)
Nausea (feeling of having an urge to vomit)
Bone disorder
Cellulitis (infection under the skin)
Confusional state
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Headache (pain in head)
Infection

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 4 people, 20.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 15.00%
Stress And Anxiety: 3 people, 15.00%
Pain: 3 people, 15.00%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 15.00%
Device Related Infection: 2 people, 10.00%
Itching: 2 people, 10.00%
Computerised Tomogram Abdomen: 2 people, 10.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 10.00%
Depression: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Armodafinil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously